Peak Bio, Inc. Warrant
PKBOW
PKBOW was delisted on the 5th of January, 2023.
17 hedge funds and large institutions have $613K invested in Peak Bio, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
13% less capital invested
Capital invested by funds: $701K → $613K (-$88K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCFM
Cohen & Co Financial Management
New York
|
+$70.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$154 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$66K |
PKBOW Hedge Fund Activity: Q3 2022 in Review
17 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q3 2022, worth a combined $613K — down 13% from $701K a quarter earlier.
Fund positioning in PKBOW was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Cohen & Co Financial Management, opening a new position worth an estimated $70.8K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $66K sold.
- 17 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $613K of Peak Bio, Inc. Warrant stock for Q3 2022, down 13% quarter-over-quarter.
- 1 fund opened new Peak Bio, Inc. Warrant positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest Peak Bio, Inc. Warrant buyer in Q3 2022 was Cohen & Co Financial Management, an estimated $70.8K added.
- The largest Peak Bio, Inc. Warrant seller in Q3 2022 was K2 Principal Fund, an estimated $66K sold.
Based on aggregated 13F filings for Q3 2022.